Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Stericycle Inc    SRCL

Delayed Quote. Delayed  - 02/12 03:59:59 pm
106.92 USD   +0.82%
02/04 STERICYCLE : tops 4Q profit forecasts
02/04 Stericycle, Inc. Reports Results for the Fourth Quarter and Full ..
01/29 STERICYCLE : Hagens Berman: Victims of Alleged Stericycle Pricing Fr..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Sales2 1432 5562 9863 6593 9144 259
Operating income (EBITDA)6457207891 0141 1211 275
Operating profit (EBIT)5566156628269231 093
Pre-Tax Profit (EBT)478-----
Net income311326255437506-
P/E ratio32,634,640,722,419,2-
EPS ( $ )3,563,792,964,785,56-
Dividend per Share ( $ )------
Yield------
Reference price ( $ )116.17131.08120.6106.92106.92106.92
Announcement Date02/05/2014
09:02pm
02/05/2015
09:02pm
02/04/2016
09:02pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Debt1 3691 6373 1581 5662 4261 824
Finance------
Operating income (EBITDA)6457207891 0141 1211 275
Leverage
(Debt/EBITDA)
2,12x2,27x4,00x1,54x2,16x1,43x
Capital Expenditure73,186,5115132136149
Book Value Per Share (BVPS)20,6 $22,4 $32,1 $33,9 $38,5 $45,9 $
Cash Flow per Share4,62 $5,20 $4,53 $5,85 $7,04 $7,71 $
Announcement Date02/05/2014
09:02pm
02/05/2015
09:02pm
02/04/2016
09:02pm
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 9 087 M$ -
Entreprise Value (EV) 10 653 M$ 11 513 M$
Valuation 2016e 2017e
P/E ratio (Price / EPS) 22,4x 19,2x
Capitalization / Revenue 2,48x 2,32x
EV / Revenue 2,91x 2,94x
EV / EBITDA 10,5x 10,3x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 3,15x 2,78x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 22,6% 23,6%
operating Leverage (Delta EBIT / Delta Sales) 1,10x 1,69x
Net Margin (Net Profit / Revenue) 11,9% 12,9%
ROA (Net Profit / Asset) 35,8% 12,5%
ROE (Net Profit / Equities) 15,6% 15,5%
Rate of Dividend - -
Balance Sheet Analysis 2016e 2017e
CAPEX / Sales   3,60% 3,47%
Cash Flow / Sales 13,6% 15,3%
Capital Intensity (Assets / Sales) 0,33x 1,04x
Financial Leverage (Net Debt / EBITDA) 1,54x 2,16x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend